Wynclark Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2007.
2007 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Wynclark Pharmaceuticals Private Limited

Wynclark Pharmaceuticals Private Limited, a active private limited company, was established on 08 February 2007 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239TG2007PTC052676. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹14.08 Cr and a paid-up capital of ₹14.08 Cr.

Formerly known as Medplus Mart Global Private Limited, Medplus Smart Private Limited. It upholds a compliant status. Employing 7 professional, Its leadership includes Sujit Kumar Mahato (Cfo), Paidiwar Srinivas (Director), Bhaskar Reddy Cherukupalli (Director). Past directors included Madhukar Reddy Gangadi, Apu Sorabh Gupta, Surendranath Mantena. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor,12-7-20/64/2, Survey No. 793, Goods Shed Road, Moosapet, Kukatpally,, Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2007PTC052676

  • Registration Number

    052676

  • Incorporation Date

    08 February 2007

  • Authorized Capital

    ₹14.08 Cr

  • Paid-Up Capital

    ₹14.08 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 14.08 Cr
  • Paid Up Capital ₹ 14.08 Cr
  • Company Age 19 Year, 21 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 40.13%
  • Profit Growth **** 24.66%
  • Ebitda **** 50.81%
  • Net Worth 61.46%
  • Total Assets **** 17.68%
Company report

Wynclark Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wynclark Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wynclark Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sujit Kumar Mahato Cfo 16 Nov 2022 Current
Paidiwar Srinivas Director 03 Aug 2013 Current
Bhaskar Reddy Cherukupalli Director 29 Sep 2021 Current
Satya Murali Krishna Kammila Whole-Time Director 29 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Jul 2012 Past
Pramod Abcsdd Director 13 Apr 2009 Past
Pramod Abcsdd Director 29 Sep 2021 Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Company Secretary 14 Jan 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wynclark Pharmaceuticals.

Wynclark Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.13% increase. The company also saw a substantial improvement in profitability, with a 24.66% increase in profit. The company's net worth Soared by an impressive increase of 61.46%.

Wynclark Pharmaceuticals revenue growth over time
Wynclark Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 40.13%
*******
*******
*******
*******
Revenue from Operations
*******
 39.79%
*******
*******
*******
*******
Total Assets
*******
 17.68%
*******
*******
*******
*******
Profit or Loss
*******
 24.66%
*******
*******
*******
*******
Net Worth
*******
 61.46%
*******
*******
*******
*******
EBITDA
*******
 50.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wynclark Pharmaceuticals?

In 2023, Wynclark Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wynclark Pharmaceuticals?

Wynclark Pharmaceuticals has a workforce of 7 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wynclark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wynclark Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wynclark Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Wynclark Pharmaceuticals Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Ritik Jain was appointed as a Company Secretary was appointed as a Company Secretary on 30 Aug 2025 & has been associated with this company since 6 months 1 day . was documented.

  • Balance Sheet

    Progress on Wynclark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Riti Gupta was appointed as a Company Secretary was appointed as a Company Secretary on 10 Jan 2023 & has been associated with this company since 3 years 1 month . was documented.

  • Director Appointment

    Progress on Sujit Kumar Mahato was appointed as a CFO was appointed as a CFO on 16 Nov 2022 & has been associated with this company since 3 years 3 months . was documented.

  • Director Appointment

    Sujit Kumar Mahato was appointed as a CFO was appointed as a CFO on 16 Nov 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wynclark Pharmaceuticals Private Limited?

The CIN of Wynclark Pharmaceuticals Private Limited is U24239TG2007PTC052676.

Where is Wynclark Pharmaceuticals Private Limited headquartered?

Wynclark Pharmaceuticals Private Limited is headquartered at Ground Floor,12-7-20/64/2, Survey No. 793, Goods Shed Road, Moosapet, Kukatpally,, Hyderabad, Telangana, 500018.

When was Wynclark Pharmaceuticals Private Limited incorporated?

Wynclark Pharmaceuticals Private Limited was incorporated on 08 February 2007.

Who are the current directors of Wynclark Pharmaceuticals Private Limited?

The current directors of Wynclark Pharmaceuticals Private Limited are

What is the primary industry of Wynclark Pharmaceuticals Private Limited?

The primary industry of Wynclark Pharmaceuticals Private Limited is Trade.

Is Wynclark Pharmaceuticals Private Limited a listed company?

Wynclark Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Wynclark Pharmaceuticals Private Limited?

The authorized capital of Wynclark Pharmaceuticals Private Limited is ₹14.08 Cr, and the paid-up capital is ₹14.08 Cr.

What is the compliance status of Wynclark Pharmaceuticals Private Limited?

The compliance status of Wynclark Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available